Do not let your joints decide for you! To do this, take exclusive turmeric extract, add Boswellia serrata and vitamin D, and and you will regain flexibilty in joints and muscles!
FLEXOFYTOL PLUS® :
A MORE COMPLETE FORMULA
FOR ENHANCED ACTION
Flexofytol PLUS® comes in tablet form and combines the 2 most studied natural solutions in the articular sphere: curcumin and boswellic acids.
Curcumin, the active principle of the turmeric root, is a powerful antioxidant that contributes to the flexibility of joints and tendons. The exclusive extract of turmeric in Flexofytol PLUS is developed in Belgium by the Tilman laboratory. It is necessary to favour the exclusive turmeric extracts in order to benefit from optimal activity.
The exclusive curcumin contained in Flexofytol PLUS helps to keep joints supple1.
Its safety of use is also documented in Belgium2.
There are 12 types of boswellic acids, active ingredients of Boswellia serrata. These boswellic acids will act synergistically to maintain joint health.
Flexofytol PLUS® contains 120 mg of Boswellia serrata extract standardized to 65% boswellic acids.
Vitamin D allows the normal development of bones and the maintenance of muscle function.
A SAFE ALTERNATIVE …
Unlike the regularly proposed alternatives in case of joint sensitivities, Flexofytol PLUS® can be used for long periods with a very good tolerance.
HOW TO USE
To be taken during meals to optimize the assimilation of Boswellia
JOINTS, MUSCLES & TENDONS
Adults and children from 12 years old
|2 tablet in the morning and in the evening,
during minimum 1 month
|2 tablet in the morning
Children from 6 to 12 years:
|2 tablet in the morning,
during minimum 1 month
|1 tablet in the morning
- Do not use during pregnancy and lactation.
- Consult your family physician or pharmacist in case of concomitant use of anticoagulants.
Flexofytol PLUS® cannot be used in children under 6 years of age.
In case of difficulties swallowing the tablet, it can be cut with a tablet cutter or crushed.
EXISTS IN 2 FORMATS
Pack of 56 tablets
Pack of 182 tablets
1 Liuting Zeng et al. 2021
2 De Breucker et al. Open Journal of Rheumatology and Autoimmune Diseases, 2017, 7, 167-177.
3 Source IQVIA – OTC Joint care systemic – november 2021